About Magritek
Magritek is a company based in Wellington (New Zealand) founded in 2004. Magritek offers products and services including Spinsolve, Autosampler, and Kea NMR-MOUSE. Magritek operates in a competitive market with competitors including Bruker, Impedimed, Rigaku, Speclipse and Anvajo, among others.
- Headquarter Wellington, New Zealand
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
European Union
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Magritek
Magritek offers a comprehensive portfolio of products and services, including Spinsolve, Autosampler, and Kea NMR-MOUSE.
High-resolution device for monitoring chemical reactions in labs.
Enhances sample throughput for benchtop NMR systems.
Portable tool for non-destructive material analysis.
People of Magritek
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Magritek
Investors in Magritek
Magritek has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Ampersand Capital Partners and Rangatira Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Locked | Locked | Locked | |
|
Investment services are offered by Rangatira Investments in New Zealand.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Magritek
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Magritek
Investment portfolio details for Magritek
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Magritek
Detailed financials for Magritek
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Magritek Comparisons
Peer comparison for Magritek
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Magritek
Magritek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bruker, Impedimed, Rigaku, Speclipse and Anvajo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diversified research instrument systems are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Technologies for non-invasive fluid status assessment and monitoring are developed.
|
|
| Locked | Locked | Locked |
XRD, XRF, SAXS, Raman, metrology, and crystallography solutions are provided.
|
|
| Locked | Locked | Locked |
Molecular spectroscopy systems for early skin cancer detection are provided.
|
|
| Locked | Locked | Locked |
Point-of-care solutions for laboratory diagnostics are provided by Anvajo.
|
|
| Locked | Locked | Locked |
Optical systems are developed for identifying solid and liquid chemicals.
|
Detailed competitors of Magritek
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Magritek
Complete news archive for Magritek
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Magritek
Magritek was founded in 2004 and raised its 1st funding round 9 years after it was founded.
Magritek is headquartered in Wellington, New Zealand.
Provider of NMR and MRI solutions for industries and research laboratories. The companys products were initially developed by research teams at RWTH University, Germany, and Massey University, and Victoria University of Wellington in New Zealand. Its flagship analytical tool, Spinsolve NMR Spectrometer allows researchers to perform proton NMR spectra measurements within seconds. A single NMR scan using the instrument can measure concentrations and reveal molecular structure for many samples. Another product Terranova-MRI, the worlds first and only 3D MRI-capable of teaching system for students and teachers in a normal laboratory environment.
Magritek's top competitors include Bruker, Impedimed and Linear Diagnostics.
Magritek offers Spinsolve, Autosampler, and Kea NMR-MOUSE.
Magritek has 3 investors. Key investors include European Union, Ampersand Capital Partners, and Rangatira Investments.